EA201692453A1 - Способ получения ингаляционных составов - Google Patents

Способ получения ингаляционных составов

Info

Publication number
EA201692453A1
EA201692453A1 EA201692453A EA201692453A EA201692453A1 EA 201692453 A1 EA201692453 A1 EA 201692453A1 EA 201692453 A EA201692453 A EA 201692453A EA 201692453 A EA201692453 A EA 201692453A EA 201692453 A1 EA201692453 A1 EA 201692453A1
Authority
EA
Eurasian Patent Office
Prior art keywords
obtaining
inhalation compositions
inhalation
compositions
relates
Prior art date
Application number
EA201692453A
Other languages
English (en)
Other versions
EA031373B1 (ru
Inventor
Али Тюркильмаз
Деврим Джелик
Озлем Акдас
Original Assignee
Арвен Иладж Санайи Ве Тиджарет А. Ш.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арвен Иладж Санайи Ве Тиджарет А. Ш. filed Critical Арвен Иладж Санайи Ве Тиджарет А. Ш.
Publication of EA201692453A1 publication Critical patent/EA201692453A1/ru
Publication of EA031373B1 publication Critical patent/EA031373B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к новому способу, используемому для получения сухих порошкообразных составов для ингаляции.
EA201692453A 2014-07-09 2015-07-08 Способ получения ингаляционных составов EA031373B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201408049 2014-07-09
PCT/EP2015/065599 WO2016005447A1 (en) 2014-07-09 2015-07-08 A process for preparing the inhalation formulations

Publications (2)

Publication Number Publication Date
EA201692453A1 true EA201692453A1 (ru) 2017-04-28
EA031373B1 EA031373B1 (ru) 2018-12-28

Family

ID=52003034

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692453A EA031373B1 (ru) 2014-07-09 2015-07-08 Способ получения ингаляционных составов

Country Status (10)

Country Link
US (1) US20170266135A1 (ru)
EP (1) EP3166594B1 (ru)
EA (1) EA031373B1 (ru)
ES (1) ES2672383T3 (ru)
GE (1) GEP20196944B (ru)
MA (1) MA40446A (ru)
PL (1) PL3166594T3 (ru)
PT (1) PT3166594T (ru)
TR (1) TR201807647T4 (ru)
WO (1) WO2016005447A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY195347A (en) 2016-10-31 2023-01-13 Thales Australia Ltd Acoustic transducer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006174A (en) * 1990-10-03 1999-12-21 Interdigital Technology Coporation Multiple impulse excitation speech encoder and decoder
EP1425001B1 (en) 2001-09-14 2008-12-17 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
WO2008023001A1 (en) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Powder formulations for inhalation containing enantiomerically pure beta-agonists
US7982521B2 (en) * 2006-10-03 2011-07-19 Freescale Semiconductor, Inc. Device and system for reducing noise induced errors
LT2400950T (lt) * 2009-02-26 2019-08-26 Glaxo Group Limited Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį
JP5792308B2 (ja) * 2010-08-31 2015-10-07 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法

Also Published As

Publication number Publication date
EP3166594B1 (en) 2018-03-07
MA40446A (fr) 2018-03-07
PT3166594T (pt) 2018-06-06
TR201807647T4 (tr) 2018-06-21
EP3166594A1 (en) 2017-05-17
GEP20196944B (en) 2019-02-11
ES2672383T3 (es) 2018-06-14
WO2016005447A1 (en) 2016-01-14
US20170266135A1 (en) 2017-09-21
PL3166594T3 (pl) 2018-09-28
EA031373B1 (ru) 2018-12-28

Similar Documents

Publication Publication Date Title
MX2023008686A (es) Polinucleotidos moduladores.
EA201692219A1 (ru) Способы получения противовирусных соединений
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
DK3107548T3 (da) Tørpulverformuleringer til inhalation
DK3325487T3 (da) Formulering til bløde, anticholinerge analoger
DK3319597T3 (da) Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater
MX2016011553A (es) Composiciones que comprenden un agente pungente.
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
TR201910057T4 (tr) Kauçuk bi̇leşi̇mleri̇
MX2018000515A (es) Compuestos fluorados de cbd, composiciones y usos de los mismos.
IN2014CH00840A (ru)
DK3179986T3 (da) Tørpulverformuleringer til inhalation
EA201690294A1 (ru) Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов
EA201691924A1 (ru) Фармацевтические композиции
IN2014CH00304A (ru)
EP3102540A4 (en) Compositions including a vacancy-engineered (ve)-zno nanocomposite, methods of making a composition, methods of using a composition
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
EA201691203A1 (ru) Твёрдые формы тенофовира
DK3076957T3 (da) Fremgangsmåde til fremstilling af tørpulverinhalationssammensætninger
EA201692453A1 (ru) Способ получения ингаляционных составов
EA201692428A1 (ru) Способ получения сухих порошкообразных составов
DK2915526T3 (da) Farmaceutiske sammensætninger, der omfatter anagrelid
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU